India's Senores Pharma up on buying generic hypertension drug from Wockhardt
** India's Senores Pharma SENO.NS rises 3% to 517.70 rupees ** Drugmaker says it acquired generic version of hypertension drug Enalapril Maleate from Wockhardt WCKH.NS ** Market size for the drug is estimated at $109.2 mln in US, says SENO citing data aggregator Symphony ** Adds, co will fund acquisition for the drug via proceeds it raised during its IPO in December 2024 ** Stock down 7% since its trading debut (Reporting by Kashish Tandon in Bengaluru) ((Kashish.tandon@thomsonreuters.com))
Recent news on Wockhardt
See all newsBrief: Wockhardt Says Customs Authority Imposes 50 Million Rupees Penalty And 100 Million Rupees Redemption Fine On Co
Brief: Wockhardt Limited June-Quarter Consol Net Profit 1.06 Billion Rupees
India's Wockhardt gains after marketing authorization for antibiotic ZAYNICH
Brief: Wockhardt Says Indian Drug Regulator Grants Marketing Authorization To Co's Zaynich
India's Wockhardt hits 7‑month high after swinging to profit in fourth quarter